Risk of diabetic ketoacidosis with SGLT2 inhibitors

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2015年 / 1566卷 / 1期
关键词：
D O I：
10.1007/s40278-015-4618-3
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1 / 1
相关论文
共 50 条
  • [1] SGLT2 inhibitors and the risk of diabetic ketoacidosis
    Redford, Christopher
    Doherty, Laura
    Smith, Jamie
    PRACTICAL DIABETES, 2015, 32 (07) : 263 - 264A
  • [2] SGLT2 inhibitors increase the risk of diabetic ketoacidosis
    Reactions Weekly, 2016, 1603 (1) : 9 - 9
  • [3] Individual SGLT2 Inhibitors and the Risk of Diabetic Ketoacidosis
    Abrahami, Devin
    D'Andrea, Elvira
    Kim, Seoyoung C.
    Wexler, Deborah J.
    Paik, Julie M.
    Patorno, Elisabetta
    DIABETES, 2022, 71
  • [4] SGLT2 inhibitors increase risk of diabetic ketoacidosis
    Reactions Weekly, 2017, 1656 (1) : 12 - 12
  • [5] Diabetic ketoacidosis with SGLT2 inhibitors
    Musso, Giovanni
    Saba, Francesca
    Cassader, Maurizio
    Gambino, Roberto
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 371
  • [6] SGLT2 inhibitors and euglycemic diabetic ketoacidosis
    Yousaf, Zohaib
    Ata, Fateen
    Khan, Adeel Ahmad
    Razok, Almurtada
    Akram, Jaweria
    Ali, Elrazi Awadelkarim Hamid
    Abdalhadi, Ahmed
    Danjuma, Mohammed I.
    Al Mohanadi, Dabia Hamad S. H.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (09) : 1431 - 1433
  • [7] SGLT2 inhibitors and euglycemic diabetic ketoacidosis
    Zohaib Yousaf
    Fateen Ata
    Adeel Ahmad Khan
    Almurtada Razok
    Jaweria Akram
    Elrazi Awadelkarim Hamid Ali
    Ahmed Abdalhadi
    Mohammed I. Danjuma
    Dabia Hamad S. H. Al Mohanadi
    European Journal of Clinical Pharmacology, 2021, 77 : 1431 - 1433
  • [8] Diabetic ketosis/ketoacidosis with SGLT2 inhibitors
    Reactions Weekly, 2019, 1754 (1) : 5 - 5
  • [9] The comparative safety of individual SGLT2 inhibitors and the risk of diabetic ketoacidosis
    Abrahami, Devin
    D'Andrea, Elvira
    Kim, Seoyoung
    Wexler, Deborah
    Paik, Julie
    Patorno, Elisabetta
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 115 - 115
  • [10] SGLT2 inhibitors increase risk for diabetic ketoacidosis in type 2 diabetes
    Griffin, Tomas P.
    Dinneen, Sean F.
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (08) : JC40 - JC40
12345